BioNTech SE (BNTX) Exchange Rate Effect (2018 - 2025)
BioNTech SE (BNTX) reported Exchange Rate Effect of $1.6 million for Q4 2025, down 88.79% on a YoY basis from $14.5 million in Q4 2024, and up 106.48% sequentially from -$25.1 million in Q3 2025.
BioNTech SE (BNTX) Exchange Rate Effect (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of Exchange Rate Effect data on file, last reported at $1.6 million in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect fell 88.79% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at -$30.0 million (down 289.55% YoY), and the FY2025 full-year result was -$30.5 million, down 292.88% from the prior year.
- Exchange Rate Effect grew to $1.6 million in Q4 2025, from -$25.1 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $865.0 million in Q4 2022 to a low of -$105.2 million in Q4 2021.
- A 5-year average of $57.5 million and a median of $4.5 million in 2024 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect slumped 191894673.21% in 2021 and surged 195979694.61% in 2022, its largest moves.
- Tracing BNTX's Exchange Rate Effect over 5 years: stood at -$105.2 million in 2021, then jumped by 921.86% to $865.0 million in 2022, then slumped by 101.92% to -$16.6 million in 2023, then surged by 187.71% to $14.5 million in 2024, then plunged by 88.79% to $1.6 million in 2025.
- Business Quant data shows BNTX's Exchange Rate Effect at $1.6 million in Q4 2025, -$25.1 million in Q3 2025, and $10.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.63 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | -25.13 Mn |
| Sep 30, 2025 | -25.13 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Mar 31, 2025 | -16.94 Mn |
| Mar 31, 2025 | -16.94 Mn |
| Dec 31, 2024 | 14.53 Mn |
| Dec 31, 2024 | 14.53 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Mar 31, 2024 | 7.39 Mn |
| Mar 31, 2024 | 7.39 Mn |
| Dec 31, 2023 | -16.57 Mn |
| Dec 31, 2023 | -16.57 Mn |
| Sep 30, 2023 | 66.62 Mn |
| Sep 30, 2023 | 66.62 Mn |